Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Campiani

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesteraseL Savini, G Campiani, A Gaeta, et al.
Biochemical Society Transactions|November 16, 2001
Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agentsD M Zisterer, M M McGee, G Campiani, et al.
Journal of Medicinal Chemistry|November 25, 1994
A comparative molecular field analysis model for 6-arylpyrrolo[2,1-d] [1,5]benzothiazepines binding selectively to the mitochondrial benzodiazepine receptorG Greco, E Novellino, I Fiorini, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-ablM M Mc Gee, G Campiani, A Ramunno, et al.
Journal of Medicinal Chemistry|May 13, 1994
Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studiesI Fiorini, V Nacci, S M Ciani, et al.
Journal of Medicinal Chemistry|November 10, 1995
A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines toward mitochondrial benzodiazepine receptorsA Dalpiaz, V Bertolasi, P A Borea, et al.
Journal of Medicinal Chemistry|October 27, 1995
Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activityG Campiani, A Garofalo, I Fiorini, et al.
Journal of Medicinal Chemistry|July 5, 1996
Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activityG Campiani, V Nacci, I Fiorini, et al.
Progress in Neurobiology|May 29, 2016
Polypharmacology of dopamine receptor ligandsS Butini, K Nikolic, S Kassel, et al.
Journal of Medicinal Chemistry|November 14, 1997
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structureG Campiani, A Cappelli, V Nacci, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesteraseL Savini, G Campiani, A Gaeta, et al.
Biochemical Society Transactions|November 16, 2001
Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agentsD M Zisterer, M M McGee, G Campiani, et al.
Journal of Medicinal Chemistry|November 25, 1994
A comparative molecular field analysis model for 6-arylpyrrolo[2,1-d] [1,5]benzothiazepines binding selectively to the mitochondrial benzodiazepine receptorG Greco, E Novellino, I Fiorini, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-ablM M Mc Gee, G Campiani, A Ramunno, et al.
Journal of Medicinal Chemistry|May 13, 1994
Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studiesI Fiorini, V Nacci, S M Ciani, et al.
Journal of Medicinal Chemistry|November 10, 1995
A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines toward mitochondrial benzodiazepine receptorsA Dalpiaz, V Bertolasi, P A Borea, et al.
Journal of Medicinal Chemistry|October 27, 1995
Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activityG Campiani, A Garofalo, I Fiorini, et al.
Journal of Medicinal Chemistry|July 5, 1996
Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activityG Campiani, V Nacci, I Fiorini, et al.
Progress in Neurobiology|May 29, 2016
Polypharmacology of dopamine receptor ligandsS Butini, K Nikolic, S Kassel, et al.
Journal of Medicinal Chemistry|November 14, 1997
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structureG Campiani, A Cappelli, V Nacci, et al.
Pageof 4